20/02/2026
PA Hospital is expanding access to cutting-edge cancer care, with the launch of a new clinical theranostics service for patients with metastatic neuroendocrine tumours. ❤️
From November 2025, PAH began offering this specialised therapy to all eligible Metro South patients, significantly broadening access to a treatment previously limited to those enrolled in specific clinical trials or requiring travel outside of Metro South HHS.
For patient Pam, the new service means so much more than just advanced treatment.
“When I heard the service was opening here, I was really excited,” she said. “It’s closer to home, and it makes such a difference. Having this service on the south side is so much more convenient, not just for me, but for other patients too.”
Previously, Pam relied on long public transport journeys across the city to attend appointments.
The introduction of the clinical theranostics service at PAH marks a significant milestone for Metro South Health, improving equity of access to highly specialised cancer treatment and reducing the burden of travel for patients living on Brisbane’s south side.